Vincent-Philippe Lavallée, a PhD student in the Sauvageau lab, received an important grant from the Vanier Canada Graduate Scholarship (Vanier CGS) program. This 3-year scholarship from the Canadian Institutes of Health Research (CIHR), rewards students that distinguish themselves for their leadership and academic excellence.
The Sauvageau lab currently accepting applications for exceptional PhD students. If you are passionate about research and interested in joining our team, please submit your application to Marie-Eve Bordeleau.
ExCellThera, a clinical-stage spin-off company based on the Sauvageau lab’s work on stem cell expansion, won the $20,000 first prize in the Pharma and Biotech category at the HealthKick Challenge, which took place in Toronto, Ontario, on April 5th.
Health Canada has officially given the green light for the first phase of clinical trials involving transplantation of cord blood cells expanded with the small molecule UM171 for the treatment of blood-related cancers. Thanks to our collaborators at IRIC and Hôpital Maisonneuve-Rosemont
Visit the new Leucegene website. Several of our lab members are involved in this project.
The public has voted this scientific breakthrough 2014 Québec Science Discovery of the Year.
Haploinsufficiency screen highlights two distinct groups of ribosomal protein genes essential for embryonic stem cell fate
Radio-Canada has bestowed the title of Scientist of the Year on Dr. Guy Sauvageau for the discovery of a molecule capable of multiplying umbilical cord blood stem cells.
Dr. Sauvageau’s team has made an unprecedented breakthrough with the discovery of a new molecule capable of multiplying the stem cells present in umbilical cord
SCL, LMO1 and Notch1 Reprogram Thymocytes into Self-Renewing Cells